Molecular Templates, Inc. (MTEM) financial statements (2022 and earlier)

Company profile

Business Address 9301 AMBERGLEN BLVD
AUSTIN, TX 78729
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments143,04493,885125,08497,95558,91023,55148,680
Cash and cash equivalents24,98325,21885,45187,72158,91010,5519,589
Short-term investments118,06168,66739,63310,234 13,00039,091
Receivables 2347,508240   
Prepaid expense3,9176,0802,3182,2441,485  
Other current assets1,2541,1254894,42419  
Other undisclosed current assets  4,500  6234,490
Total current assets:148,215101,324139,899104,86360,41424,17453,170
Noncurrent Assets
Operating lease, right-of-use asset8,60811,1049,959
Property, plant and equipment19,30922,25418,1586,8511,952109333
Long-term investments and receivables8,986 1,510    
Long-term investments8,986 1,510    
Other noncurrent assets7,2445,1954,6761,8211,402 166
Other undisclosed noncurrent assets   26,62326,623  
Total noncurrent assets:44,14738,55334,30335,29529,977109499
TOTAL ASSETS:192,362139,877174,202140,15890,39124,28353,669
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,12714,92516,0096,1375,2071,7103,994
Accounts payable1,6122,3501,4657802,517822725
Accrued liabilities9,51512,57514,5445,3572,6908883,269
Deferred revenue32,93714,01417,291
Debt   332,400  
Deferred revenue and credits2,765  
Other liabilities2,6062,2112,50114170  
Other undisclosed current liabilities 6,403 26,198 9066,834
Total current liabilities:46,67037,55335,80132,50910,4422,61610,828
Noncurrent Liabilities
Long-term debt and lease obligation45,05527,13914,6223,2711,078  
Long-term debt, excluding current maturities35,49114,9262,9403,2541,078  
Capital lease obligations17   
Operating lease, liability9,56412,21311,682
Liabilities, other than long-term debt34,9756,02820,7518191,5821,7791,995
Deferred revenue and credits 36131
Deferred revenue33,3504,53819,385
Other liabilities1,6251,4901,366816628  
Derivative instruments and hedges, liabilities   39541,7431,864
Other undisclosed noncurrent liabilities 9,817 2,653   
Total noncurrent liabilities:80,03042,98435,3736,7432,6601,7791,995
Total liabilities:126,70080,53771,17439,25213,1024,39512,823
Stockholders' equity
Stockholders' equity attributable to parent65,66259,340103,028100,90677,28919,88840,846
Common stock56504637277271
Additional paid in capital417,704328,314267,089195,573141,733373,352370,236
Accumulated other comprehensive income (loss)(48)1718  (2)(21)
Accumulated deficit(352,050)(269,041)(164,125)(94,704)(64,471)(353,534)(329,440)
Total stockholders' equity:65,66259,340103,028100,90677,28919,88840,846
TOTAL LIABILITIES AND EQUITY:192,362139,877174,202140,15890,39124,28353,669

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues  22,27013,2853,395 76,915
Revenue, net987 76,915
Gross profit:  22,27013,2853,395 76,915
Operating expenses(118,771)(119,687)(92,719)(44,284)(21,242)(24,362)(49,987)
Other undisclosed operating income38,69718,845     
Operating income (loss):(80,074)(100,842)(70,449)(30,999)(17,847)(24,362)26,928
Nonoperating income  3  12116,769
Investment income, nonoperating  3    
Other nonoperating income     12116,769
Interest and debt expense(146)(1,237)(2)(115)(5,472)  
Other undisclosed income from continuing operations before equity method investments, income taxes     147125
Income (loss) from continuing operations before equity method investments, income taxes:(80,220)(102,079)(70,448)(31,114)(23,319)(24,094)43,822
Other undisclosed loss from continuing operations before income taxes(2,789)(2,832)     
Income (loss) from continuing operations before income taxes:(83,009)(104,911)(70,448)(31,114)(23,319)(24,094)43,822
Income tax expense (5)     
Net income (loss):(83,009)(104,916)(70,448)(31,114)(23,319)(24,094)43,822
Other undisclosed net income attributable to parent  1,027827179  
Net income (loss) attributable to parent:(83,009)(104,916)(69,421)(30,287)(23,140)(24,094)43,822
Preferred stock dividends and other adjustments    (958)  
Net income (loss) available to common stockholders, basic:(83,009)(104,916)(69,421)(30,287)(24,098)(24,094)43,822
Dilutive securities, effect on basic earnings per share      (3,906)
Net income (loss) available to common stockholders, diluted:(83,009)(104,916)(69,421)(30,287)(24,098)(24,094)39,916

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(83,009)(104,916)(70,448)(31,114)(23,319)(24,094)43,822
Other comprehensive income (loss)(65)(1)18    
Comprehensive income (loss):(83,074)(104,917)(70,430)(31,114)(23,319)(24,094)43,822
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  1,027827(779)19(8)
Comprehensive income (loss), net of tax, attributable to parent:(83,074)(104,917)(69,403)(30,287)(24,098)(24,075)43,814

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: